ZURICH/WASHINGTON: After being banned in India on health concerns, Maggi noodles manufactured by Swiss giant Nestle in India has come come under the scanner of the US Food and Drug Administration (USFDA), which has taken samples of the instant food brand for testing.
Besides selling in India, Nestle India also exports Maggi noodles to the US, Canada, UK, Australia, Singapore and Kenya, as per the global website of the Swiss multinational giant.
“We have been made aware that the (US) FDA has taken samples of Maggi noodles manufactured in India from third-party importers’ containers for testing, and we have asked the importers to advise us of the outcome of the FDA tests,” a Nestle SA spokesperson said in an emailed statement.
The spokesperson, however, said Nestle USA does not import, market or distribute Maggi noodles in the United States.
“Any Maggi noodle products found on US store shelves are sourced directly by retailers or imported through third-party trade,” she added.
Authorities in Kenya and the UK are also testing Maggi samples. The food regulator in Singapore had also tested the samples, but later found that Maggi noodles imported from India were safe to eat.
Meanwhile, Nestle India said it has approached the Bombay High Court against the ban of Maggi noodles by central food safety regulator FSSAI and Maharashtra Food and Drug Administration.
“As part of the efforts to resolve the Maggi noodles issue, Nestle India has approached the Bombay High Court, raising issues of interpretation of the Food Safety and Standards Act, 2011 while seeking a judicial review of the order dated June 6, 2015, passed by the Food and Drug Administration (FDA) in Maharashtra and the order dated June 5 passed by FSSAI,” Nestle India said in a filing to the BSE.
“At the same time, we are continuing withdrawal of Maggi noodle products. This action will not interfere with this process,” it added.-PTI
